LabMedica

Download Mobile App
Recent News Expo
Medica 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Clinical Chemistry

Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Werfen’s Aptiva Antiphospholipid Syndrome Immunoglobulin A (IgA) Reagent has received U.S. FDA 510(k) clearance and CE Mark under IVDR. More...
23 Sep 2026
Image: GRAIL’s Galleri test uses machine learning to analyze cfDNA patterns for cancer signals and predict their likely location to guide further evaluation.

Multi-Cancer Blood Test Expands Detection to Cancers Lacking Routine Screening Options

New findings show that adding a MCED blood test to standard screening increased early cancer detection 6.5-fold with 99.6% specificity. More...
23 Sep 2026
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

A new blood test helps guide antiplatelet treatment after heart attack or stroke by flagging clotting or bleeding risk. More...
22 Sep 2026
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

New data show CGM metrics flag higher hypertension and cholesterol risk in adults without diabetes. More...
18 Sep 2026
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

New data show trend analysis of routine blood tests with unexplained weight loss better flags patients at risk of cancer. More...
18 Sep 2026
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

An AI-enabled multi-biomarker blood test detects early-stage pancreatic cancer (87% sensitivity) and flags high-grade dysplasia. More...
16 Sep 2026
Image Credit: Diane E. MacDougall et al., FIND Lp(a) Machine Learning Model: Targeted Screening Enrichment of Elevated Lipoprotein(a) in Atherosclerotic Cardiovascular Disease, JACC: Advances (2026). DOI: 10.1016/j.jacadv.2026.103114

Machine Learning Supports Targeted Screening for Elevated Lipoprotein(a)

An AI approach leverages EMR data to target Lp(a) screening, finding ASCVD patients over 2x likelier to have high levels. More...
16 Sep 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Gold Member
Aspiration System
VACUSAFE


The Clinical Chemistry channel updates the reader on tests, techniques, and research in the field - from routine assays to specialized tests on blood, urine, enzymes, lipids, hormones and more.